Physician profile
Audra Puffer
NPI 1205311719
$863.87
in general payments reported to CMS, 2019-2025
9 companies · $218 in 2025
The $218 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $132 · 2023: $49.97 · 2024: $464 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $732.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $731.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik Nro, INC. | $279.43 | 2024 | Prospera |
| Boston Scientific Corporation | $124.17 | 2025 | Watchman Flx |
| Astrazeneca Pharmaceuticals LP | $116.15 | 2024 | Airsupra |
| Scpharmaceuticals INC. | $93.54 | 2025 | |
| Cmp Pharma, INC. | $83.79 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $49.97 | 2023 | Rexulti |
| Xeris Pharmaceuticals, INC. | $48.22 | 2022 | |
| Sk Life Science, INC. | $34.76 | 2024 | |
| Lilly USA, LLC | $33.84 | 2024 | Olumiant, Taltz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Audra Puffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.